Indian pharma giants target bigger share of $145 billion US cancer drug market
New Delhi, April 18 (IANS) Indian pharmaceutical companies are ramping up efforts to expand their footprint in the lucrative US oncology generics market, which is currently valued at $145 billion and growing at a robust pace of 11 per cent annually, according to a new report.